Dr. Von Eschenbach,
Is it FDA policy to lie when the truth will do better? Affirmative!
I filed a formal petition for the banning of aspartame five years ago. The law requires an answer within 180 days. The response I received was a letter stating FDA has more important things to do. A global plague - Aspartame disease – rampages and is ignored, disabling millions. Read Aspartame Disease: An Ignored Epidemic by H. J. Roberts, M.D. aspartame petition
Indeed FDA has more important things to do, like approving Vioxx for a body count of 55,000.
Since my deeply documented petition, aspartame’s diseases have skyrocketed: birth defects, retardation, autism, brain cancer, seizures, sexual dysfunction (count the Viagra ads), lupus, MS and death. A 1038 page medical text gives hundreds of case histories. Even FDA once listed of 92 reactions including death from over 10,000 consumer complaints, more protests than ever before received on a “food additive”. Our sleeping watchdog’s response was to kill the report 10 years ago, and deny it ever existed.
Could any of this be connected with the parade of FDA officials who got fat jobs in the aspartame biz? Is the ocean wet?
The horror reports didn't stop when FDA closed the complaint window; I’ve received tens of thousands about this addictive, neurotoxic carcinogen. To FDA’s Mitchell Cheeseman I reviewed their crimes in the approval process together with the damning protest of the National Soft Drink Assn against aspartame approval published in the Congressional Record. I called his attention to the adulteration issue NSDA brought up, then I reminded him that it’s against the law to market an adulterated product or ship it interstate.
Cheeseman cavalierly announced: "We can get around the adulteration with section 409". FDA doesn't care how lethal aspartame is, only how to get around the law. He couldn’t respond to the statement of FDA's own toxicologist, Dr. Adrian Gross, who told Congress that aspartame, violates the Delaney Amendment, which forbids anything in food that produces cancer in animals.
Break the law, ignore the law, get around the law; it’s all the same to the Fatal Drugs Allowed gang!
Aspartame is sold as an additive tho FDA knows it’s a drug that interacts with all drugs and vaccines: I told Cheeseman: “If anybody knows how deadly aspartame is, it's FDA, since they revoked the petition for approval in l980.” He lied and said there wasn’t any petition. I emailed him a copy and he changed his tune.
When the 3-year Ramazzini Study on 1,800 rats confirmed FDA's original records by showing aspartame is a multipotential carcinogen, FDA lied once more. http://www.wnho.net/cancer_study_obligates_recall.htm
When FDA was interviewed by the New York Times it all came out, they spoke from the heart and whined that “The economics would hurt the manufacturers if they banned it.” Kill the consumers but don't hurt Big Daddy’s checkbook. http://www.nytimes.com/2006/02/12/business/yourmoney/12sweet.html?ex=1297400400&en=f5f573accc334534&ei=5088&partner=rssnyt&emc=rss
Dr. Von Eschenbach, what does it take for FDA to tell the truth? http://www.thenhf.com/fda_89.htm
So now, Dr. Von Eschenbach, you’re under investigation for lying to Congress. Be proud that your tenure has endured beyond the 2 months of your predecessor, dog doctor Lester Crawford. A veterinarian, over a sleeping watchdog, it fits!
Why, you've been our FDA Commissioner 3 months already! All’s well that Ends!
Dr. Betty Martini, D.Hum, Founder
Mission Possible International
9270 River Club Parkway
Duluth, Georgia 30097 770 242-2599
www.wnho.net and www.dorway.com
www.mpwhi.com Aspartame Information List
www.holisticmed.com/aspartame The Aspartame Toxicity Center
New York Times
March 30, 2007
Dems Question FDA Chief's Testimony
By THE ASSOCIATED PRESS
Filed at 10:28 p.m. ET
WASHINGTON (AP) -- House Democrats are investigating whether FDA Commissioner Andrew von Eschenbach lied under oath about the antibiotic Ketek, which has long been under scrutiny by Congress.
The seriousness of the inquiry was outlined in a letter sent Thursday to Health and Human Services Secretary Mike Leavitt. The letter requested that the department make available by the close of business Wednesday all documents used to prepare von Eschenbach for his testimony. Also, the lawmakers asked Leavitt to make available all senior staff and counsel who participated in preparing him for his testimony.
The employees who assisted von Eschenbach will be allowed to have personal attorneys with them at the questioning, but no other employees of the department will be allowed to participate in the interviews.
The letter was signed by Reps. John Dingell, chairman of the House Energy and Commerce Committee, and Bart Stupak, chairman of the committee's oversight and investigations subcommittee. Both lawmakers are Democrats. No Republicans signed the letter.
Bill Hall, a spokesman for the Health and Human Services Department, said officials were still reviewing the letter on Friday and will determine in a timely fashion what the appropriate response will be. Neither Hall nor an FDA spokesman had further comment.
The Food and Drug Administration approved Ketek in 2004 to treat respiratory tract infections, bronchitis, sinusitis and community-acquired pneumonia. However, in February, the agency restricted the drug's use only to treat pneumonia and not the less-serious illnesses.
The agency said it and manufacturer Sanofi-Aventis SA also created a guide for patients outlining the drug's risks and its safe use.
At a hearing by his subcommittee on March 22, Stupak aggressively questioned von Eschenbach about a questionable study of the drug before it was approved. The study was marred by fraud involving one of the 1,800 sites that enrolled patients given the drug.
But Von Eschenbach said the study was not used as part of the decision to approve Ketek.
''That is false,'' Stupak said during the hearing.
The congressman said he believed the doctor was being forthright. ''But whoever is doing your work is trying to lead this committee down the wrong path. We know these issues. We are on top of these issues, so when you come and give us testimony that isn't accurate, we are going to call you on it,'' Stupak said.
On the Net:
House Energy and Commerce Committee: http://energycommerce.house.gov